update

EU and US agree to share API and drug plant inspection data

By Gareth Macdonald contact

- Last updated on GMT

iStock/meshmerize
iStock/meshmerize

Related tags: Eu member states, European union

The EU and US have agreed to recognize drug and API manufacturing plant inspections conducted in their respective territories under a deal signed this week.

The agreement​  will allow the European Medicines Agency (EMA) to use data from US Food and Drug Administration (FDA) inspections and vice versa from November.

It also means EU authorities will only visit US sites in exceptional circumstances.

According to the European Commission the agreement “facilitates the exchange of official GMPs documents​” and enables “reliance on the factual findings in such documents​.”

The Commission also said it will allow national competent authorities from EU Member States - which conduct inspections under EMA guidance - and the US FDA to make better use of inspection resources and avoid duplicate site visits.

It added that: "The enhanced cooperation with US regulatory authorities will improve the EU's ability to identify and address problems at factories before they become a public health risk.

"It will also reduce the administrative burdens and costs facing pharmaceutical manufacturers, including smaller producer​s."

The deal builds on the EU-US Mutual Recognition Agreement (MRA) signed in 1998​.

The EMA told us "The EU and the US signed the Agreement on Mutual Recognition between the European Community and the United States of America in 1998. The agreement included a Pharmaceutical Annex providing reliance on each other’s good manufacturing practice (GMP) inspections.

"However, this was never fully implemented. The 2017 Amended Sectoral Annex is building on the 1998 framework. It benefits from the collaboration of the EU and the US in the past years through various pilot initiatives on GMP inspections​."

TTIP pause

The European Commission suggested a deal was close last October in a report​ on the 15th​ round of negotiations of the proposed Transatlantic Trade and Investment Partnership (TTIP).

Since then the TTIP negotiations have halted​. On January 24, EU Trade Commissioner Cecilia Malmström said "the election of Donald Trump seems likely to put our EU-US negotiations firmly in the freezer at least for a while​."

However, a document​ published a few days before Commisioner Malmstrom's speech indicated that an inspection deal had already been ageed.

Related news

Show more

Related products

show more

Facilities: Lexington, KY USA

Facilities: Lexington, KY USA

Piramal Pharma Solutions | 23-Aug-2021 | Insight Guide

The Piramal Pharma Solutions facility in Lexington, KY USA is a fully integrated site which offers analytical, formulation development, and manufacturing...

Facilities: Sellersville, PA USA

Facilities: Sellersville, PA USA

Piramal Pharma Solutions | 23-Aug-2021 | Insight Guide

The Piramal Pharma Solutions facility in Sellersville, PA USA is a fully integrated site that offers product and process development, clinical supply and...

Facilities: Riverview, MI USA

Facilities: Riverview, MI USA

Piramal Pharma Solutions | 26-Jul-2021 | Insight Guide

The Piramal Pharma Solutions facility in Riverview, MI, USA can support your Drug Substance (API) needs. The site has extensive experience in safely delivering...

Related suppliers

Follow us

Products

View more

Webinars